Home›People›Kevin Kotler
KK

Kevin Kotler

Director at Synchrony Medical.

DirectorPublic company
Updated Nov 11, 2026·Latest SEC filing Mar 10, 2026·Suggest an edit

About Kevin Kotler

Kevin Kotler is a director at Synchrony Medical.

Kevin Kotler reports to the SEC as a director or major shareholder of 13 public companies, including Heron Therapeutics (HRTX), Biodelivery Sciences International (BDSI) and Novelion Therapeutics (NVLNF).

Kevin Kotler first appears on SEC filings in 2014.

Experience

This experience comes from Kevin Kotler's profile and from SEC filings. For roles taken from filings, the years are when the filings name Kevin Kotler in the role, so the role may have started earlier or lasted longer.

Synchrony Medical Inc. Current
Director
2026 – Present · Jersey City, NJ
Makes an at-home airway clearance device for people with chronic lung disease.
New York Angels Current
Member
2021 – Present
Hamptons United Current
Co-Founder
2020 – Present
Broadfin Holdings LLC Current
Founder & CIO (2020 – Present)
Managing Member and Chief Investment Officer (2005 – 2024)
2005 – Present
Curonix
Board Member
2022 – 2024
Heron Therapeutics, Inc.
Director
2023 · Public company (HRTX)
Biodelivery Sciences International Inc.
Director
2018 – 2022 · Public company (BDSI)
Novelion Therapeutics Inc.
Director and 10% owner
2016 – 2020 · Public company (NVLNF)
Avadel Pharmaceuticals PLC
Director and 10% owner
2017 – 2019 · Public company (AVDL)
Aratana Therapeutics, Inc.
10% owner
2017 – 2019 · Public company (PETX)
Corium International, Inc.
10% owner
2017 – 2018 · Public company (CORI)
Societal CDMO, Inc.
10% owner
2014 – 2018 · Public company (SCTL)
Mirati Therapeutics, Inc.
10% owner
2017 · Public company (MRTX)
Progenics Pharmaceuticals Inc.
10% owner
2014 – 2017 · Public company (PGNX)
Aegerion Pharmaceuticals, Inc.
10% owner
2015 – 2016 · Public company (AEGR)
STRATA Skin Sciences, Inc.
10% owner
2014 – 2016 · Public company (SSKN)
Dextera Surgical Inc.
Reporting person
2015 · Public company (DXTR)
Travere Therapeutics, Inc.
10% owner
2015 · Public company (TVTX)
The Galleon Group
Portfolio Manager
2002 – 2005
ABN AMRO
Senior Analyst - Medical Technologies and Supplies
2001 – 2002
ING Barings
Senior Analyst - Medical Technologies and Supplies
1999 – 2000
UBS Securities Co., Ltd
Medical Technology Analyst
1994 – 1998
Furman Selz Inc
Medical Technology Associate
1993 – 1994

Key Colleagues at Startups

The people Kevin Kotler works with at each company, as listed on that company's latest Form D.

Synchrony Medical Inc. · Form D/A, Mar 10, 2026
EK
Eileen Ke
Director
AS
Anat Shani
CEO and director
ED
Elad Dushack
Director
SP

Sources

  1. SECSynchrony Medical Inc. Form D/A, filed Mar 10, 2026
  2. SECForms 3, 4 and 5 filed by Kevin Kotler (SEC filer 1601692)